Xencor Inks Second Deal With Janssen Pharmaceuticals This Year | Los Angeles Business Journal

Retrieved on: 2021-10-11 07:05:23

Tags for this article:

Drugs

MorphoSys

Medicine

Monoclonal antibodies

Orphan drugs

Immunosuppressants

Janssen Pharmaceutica

Click the tags to see associated articles and topics

Xencor Inks Second Deal With Janssen Pharmaceuticals This Year | Los Angeles Business Journal. View article details on HISWAI: https://labusinessjournal.com/news/2021/oct/11/xencor-inks-second-deal-janssen-pharmaceuticals-ye/

Excerpt

Tafasitamab is a monoclonal antibody that Xencor licensed to Planegg, Germany-based ... For antibodies that are developed without the plamotamab molecule, ...

Article found on: labusinessjournal.com

View Original Article